# FDA 483 - Lonza AG - April 04, 2025

Source: https://www.globalkeysolutions.net/records/483/lonza-ag/49d1c9a6-62e9-4d01-a2a3-bb792f53a7b4

> FDA 483 for Lonza AG on April 04, 2025. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Lonza AG
- Inspection Date: 2025-04-04
- Product Type: drugs
- Office Name: Division of Clinical Evidence and Analysis 1 (Clinical Policy and Quality)

## Related Officers

- [ Investigator, Consumer Safety Officer](https://www.globalkeysolutions.net/people/thuy-nguyen/1cfb5467-f0b7-49b8-85c1-00373692e35e)
- [Hyung-yul Lee](https://www.globalkeysolutions.net/people/hyung-yul-lee/a790a804-2e43-4901-8d7d-0c656c464f0f)
- [Melissa D. Ray](https://www.globalkeysolutions.net/people/melissa-d-ray/d3edab82-132c-4a8f-997a-19d610a4f03a)

Company: https://www.globalkeysolutions.net/companies/lonza-ag/ae6ae7d7-accc-487a-8d1c-6de734a1944b

Office: https://www.globalkeysolutions.net/offices/division-of-clinical-evidence-and-analysis-1-clinical-policy-and-quality/5f95da17-30bb-423f-b892-5ea041823fbd